Search
forLearn
5 / 801 resultsResearch
5 / 41 resultsresearch REVIEW STUDY OF EFFECT OF MADHUKADI TAILA NASYA WITH PATOL PATRA SWARASA LEPA IN THE MANAGEMENT OF INDRALUPTA WITH SPECIAL REFRENCE TO ALOPECIA AREATA
The treatment may help regrow hair in Alopecia Areata.
research A REVIEW ON MALTADYA TAIL: A POLYHERBAL FORMULATION FOR INDRALUPTA
Maltadya Tail might be a good, affordable, and easy-to-use treatment for hair loss.
research Study on Samprapti of Khalitya W.S.R to Alopecia and to Evaluate the Upasaya with Bhringarajadi Taila.
Bhringarajadi Taila effectively reduces hair fall and promotes hair growth.
research A Case Study on OPD Level Management of Infertility due to PCOS with Ayurvedic Medicines
Ayurvedic treatment helped a woman with PCOS conceive and deliver a healthy baby.
research EFFECT OF KANCHNAR TWAK KWATH WITH SHUNTHI CHURNA AND NIMB TAIL NASYA IN HYPOTHYROIDISM: A CASE STUDY
Ayurvedic treatment improved symptoms and reduced TSH levels in a hypothyroidism patient.
Community Join
5 / 1000+ resultscommunity GT20029. Kintor Pharma’s Product
The conversation discusses GT20029, a compound by Kintor Pharma that degrades androgen receptors and is in trials, with potential as a hair loss cure. Another promising treatment mentioned is an antibody that blocks prolactin and has shown positive results in macaques.
community Potentially Positive Pyrilutamide News Coming
Kintor Pharmaceutical's stock rise suggests potential positive news about Pyrilutamide, a topical anti-androgen. GT20029 may also compete with existing treatments like finasteride and dutasteride.
community Simulative evaluation of taurine against alopecia caused by stress in Caenorhabditis elegans. - PubMed
Taurine shows potential in combating hair loss caused by chemical stress, especially when combined with other treatments like finasteride. Finasteride demonstrated better stress-reducing effects in the study.
community First patient dosed with Pyrilutamide (Kintor) Phase III
First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.
community Kintor Phase 2 Results released KX-826 (pyrilutamide)
Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.